Global insurer RSA has made its first external investment in a financial technology company – Pitpatpet.

activity monitor
PitPat dog activity monitor.

The tech firm is creator of the PitPat dog activity monitor and dog care intelligence data platform. PitPat attaches quickly and securely to a dog’s collar and has more than a year of battery life.

Daily activity goal

Owners download the free iOS or Android app and create a profile for their pet, based on the dog’s age, breed and weight. PitPat suggests a daily activity goal to help owners keep their pet fit and healthy by making informed lifestyle choices.

Owners can view daily updates on their pet’s activity levels, noting how much walking, running, playing and resting they have been doing – and seeing a daily count of “calories burnt”.

The Kennel Club estimates between 30% and 60% of Britain’s 8.5 million dogs are obese, and rising annually.

PitPatReal-time data

Kenny Leitch, global connected insurance director at RSA, said: “There is no NHS for pets – we essentially provide private health insurance for dogs and, just like the human health care market, education and encouraging prevention of disease is paramount.

“The really clever element here is owners can, for the first time, use real-time data to monitor how their pet is behaving and how that might affect their health. This information is designed to help owners make smart decisions to prevent disease. We want to help our customers give their dogs the best and healthiest life possible.

“PitPat offers us a powerful and practical way of generating lots of secure and robust data about 200 breeds of dogs that is incredibly easy for us and valuable for our customers.”

View your activity >

Leave a Reply

Be the First to Comment!

Notify of


related content

New practice in Rubery, Worcestershire hosted more than 100 pet owners from the local community for the day, where a charity raffle for The Cinnamon Trust also took place.

2 mins

The European Commission has granted marketing authorisation for Cytopoint (lokivetmab), the first monoclonal antibody (mAb) therapy approved in the European Union for veterinary use.

3 mins

A “disproportionately high” number of vets reported to have experienced adverse events from the use of authorised veterinary medicines were female, according to the latest pharmacovigilance report from the VMD.

5 mins

The Worldwide Veterinary Service has until August to raise £250,000 to retain its Care for Dogs shelter in northern Thailand.

3 mins

Catherine Bovens discusses various methods of diagnosis and treatment for this common autoimmune disease present in dogs.

37 mins

Practices can register for the UK’s third Pet Allergy Week, set for 5-11 June 2017.

2 mins